Wan Na, Chen Zhao, Wan Linlin, Tang Beisha, Jiang Hong
Department of Neurology, Xiangya Hospital, Central South University, Changsha, China.
National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Front Neurosci. 2020 Aug 4;14:749. doi: 10.3389/fnins.2020.00749. eCollection 2020.
Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is a progressive autosomal dominantly inherited cerebellar ataxia characterized by the aggregation of polyglutamine-expanded protein within neuronal nuclei in the brain, which can lead to brain damage that precedes the onset of clinical manifestations. Magnetic resonance imaging (MRI) techniques such as morphometric MRI, diffusion tensor imaging (DTI), functional magnetic resonance imaging (fMRI), and magnetic resonance spectroscopy (MRS) have gained increasing attention as non-invasive and quantitative methods for the assessment of structural and functional alterations in clinical SCA3/MJD patients as well as preclinical carriers. Morphometric MRI has demonstrated typical patterns of atrophy or volume loss in the cerebellum and brainstem with extensive lesions in some supratentorial areas. DTI has detected widespread microstructural alterations in brain white matter, which indicate disrupted brain anatomical connectivity. Task-related fMRI has presented unusual brain activation patterns within the cerebellum and some extracerebellar tissue, reflecting the decreased functional connectivity of these brain regions in SCA3/MJD subjects. MRS has revealed abnormal neurochemical profiles, such as the levels or ratios of N-acetyl aspartate, choline, and creatine, in both clinical cases and preclinical cases before the alterations in brain anatomical structure. Moreover, a number of studies have reported correlations of MR imaging alterations with clinical and genetic features. The utility of these MR imaging techniques can help to identify preclinical SCA3/MJD carriers, monitor disease progression, evaluate response to therapeutic interventions, and illustrate the pathophysiological mechanisms underlying the occurrence, development, and prognosis of SCA3/MJD.
3型脊髓小脑共济失调/马查多-约瑟夫病(SCA3/MJD)是一种进行性常染色体显性遗传性小脑共济失调,其特征是大脑神经元核内多聚谷氨酰胺扩展蛋白的聚集,这可导致在临床表现出现之前的脑损伤。诸如形态计量磁共振成像(MRI)、扩散张量成像(DTI)、功能磁共振成像(fMRI)和磁共振波谱(MRS)等MRI技术,作为评估临床SCA3/MJD患者以及临床前携带者的结构和功能改变的非侵入性和定量方法,已受到越来越多的关注。形态计量MRI已显示小脑和脑干萎缩或体积减少的典型模式,在一些幕上区域有广泛病变。DTI已检测到脑白质广泛的微观结构改变,这表明脑解剖连接性中断。与任务相关的fMRI已呈现小脑和一些小脑外组织内异常的脑激活模式,反映了SCA3/MJD受试者中这些脑区功能连接性的降低。MRS已揭示在脑解剖结构改变之前,临床病例和临床前病例中异常的神经化学特征,如N-乙酰天门冬氨酸、胆碱和肌酸的水平或比率。此外,一些研究报告了MRI改变与临床和遗传特征之间的相关性。这些MRI技术的实用性有助于识别临床前SCA3/MJD携带者、监测疾病进展、评估对治疗干预的反应,并阐明SCA3/MJD发生、发展和预后的病理生理机制。